Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines

Tamoxifen is a long-known anti-tumor drug, which is the gold standard therapy in estrogen receptor (ER) positive breast cancer patients. According to previous studies, the conjugation of the original tamoxifen molecule with different functional groups can significantly improve its antitumor effect....

Full description

Saved in:
Bibliographic Details
Main Authors: Márton Kalabay (Author), Zsófia Szász (Author), Orsolya Láng (Author), Eszter Lajkó (Author), Éva Pállinger (Author), Cintia Duró (Author), Tamás Jernei (Author), Antal Csámpai (Author), Angéla Takács (Author), László Kőhidai (Author)
Format: Book
Published: MDPI AG, 2022-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d056e206006744b4a549989a7e47e9a0
042 |a dc 
100 1 0 |a Márton Kalabay  |e author 
700 1 0 |a Zsófia Szász  |e author 
700 1 0 |a Orsolya Láng  |e author 
700 1 0 |a Eszter Lajkó  |e author 
700 1 0 |a Éva Pállinger  |e author 
700 1 0 |a Cintia Duró  |e author 
700 1 0 |a Tamás Jernei  |e author 
700 1 0 |a Antal Csámpai  |e author 
700 1 0 |a Angéla Takács  |e author 
700 1 0 |a László Kőhidai  |e author 
245 0 0 |a Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines 
260 |b MDPI AG,   |c 2022-03-01T00:00:00Z. 
500 |a 10.3390/ph15030314 
500 |a 1424-8247 
520 |a Tamoxifen is a long-known anti-tumor drug, which is the gold standard therapy in estrogen receptor (ER) positive breast cancer patients. According to previous studies, the conjugation of the original tamoxifen molecule with different functional groups can significantly improve its antitumor effect. The purpose of this research was to uncover the molecular mechanisms behind the cytotoxicity of different ferrocene-linked tamoxifen derivates. Tamoxifen and its ferrocene-linked derivatives, T5 and T15 were tested in PANC1, MCF7, and MDA-MB-231 cells, where the incorporation of the ferrocene group improved the cytotoxicity on all cell lines. PANC1, MCF7, and MDA-MB-231 express ERα and GPER1 (G-protein coupled ER 1). However, ERβ is only expressed by MCF7 and MDA-MB-231 cells. Tamoxifen is a known agonist of GPER1, a receptor that can promote tumor progression. Analysis of the protein expression profile showed that while being cytotoxic, tamoxifen elevated the levels of different tumor growth-promoting factors (e.g., Bcl-XL, Survivin, EGFR, Cathepsins, chemokines). On the other hand, the ferrocene-linked derivates were able to lower these proteins. Further analysis showed that the ferrocene-linked derivatives significantly elevated the cellular oxidative stress compared to tamoxifen treatment. In conclusion, we were able to find two molecules possessing better cytotoxicity compared to their unmodified parent molecule while also being able to counter the negative effects of the presence of the GPER1 through the ER-independent mechanism of oxidative stress induction. 
546 |a EN 
690 |a tamoxifen 
690 |a GPER1 
690 |a ferrocene 
690 |a oxidative stress 
690 |a cytotoxicity 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 15, Iss 3, p 314 (2022) 
787 0 |n https://www.mdpi.com/1424-8247/15/3/314 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/d056e206006744b4a549989a7e47e9a0  |z Connect to this object online.